Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol

Cancer Lett. 2007 Dec 8;258(1):63-9. doi: 10.1016/j.canlet.2007.08.011. Epub 2007 Oct 4.

Abstract

Lysophosphatidic acid (LPA) is a bioactive phospholipid that is involved in various cellular events, including tumor invasion and metastasis. In the present study, we investigated the effects of LPA and hypoxia on HIF-1alpha and VEGF expression, as well as the effect of resveratrol on LPA and hypoxia-induced HIF-1alpha and VEGF expression and human ovarian cancer cell migration. Our results show that LPA treatment under hypoxia increases HIF-1alpha protein level, which leads to increased expression of VEGF protein and mRNA. These increases in HIF-1alpha and VEGF expression are dramatically attenuated by resveratrol. The underlying mechanism of inhibition of HIF-1alpha expression by resveratrol seems to be associated with both inactivation of p42/p44 MAPK and p70S6K, as well as enhanced degradation of HIF-1alpha protein, resulting in profound decrease in VEGF expression and cell migration. Collectively, these results show that LPA under hypoxic condition enhances cell migration through the sequential induction of HIF-1alpha and VEGF, and that this enhancement is efficiently blocked by resveratrol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Blotting, Western
  • Cell Hypoxia*
  • Cell Line, Tumor / drug effects
  • Cell Line, Tumor / metabolism
  • Cell Movement
  • Female
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / antagonists & inhibitors*
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Lysophospholipids / pharmacology*
  • Mitogen-Activated Protein Kinases / metabolism
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / pathology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Resveratrol
  • Reverse Transcriptase Polymerase Chain Reaction
  • Ribosomal Protein S6 Kinases, 70-kDa / metabolism
  • Stilbenes / pharmacology*
  • Transfection
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents, Phytogenic
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Lysophospholipids
  • RNA, Messenger
  • Stilbenes
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Ribosomal Protein S6 Kinases, 70-kDa
  • Mitogen-Activated Protein Kinases
  • lysophosphatidic acid
  • Resveratrol